Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Plandai Biotechnology, Inc. | Financial_Report.xls |
10-Q - FORM 10-Q - Plandai Biotechnology, Inc. | plpl_form10q12312011v1221201.htm |
EX-31 - EXHIBIT 31 - Plandai Biotechnology, Inc. | exhibit31.htm |
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Plandai Biotechnology, Inc. (the "Company") on Form 10-Q for the period ending December 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Roger Duffield, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of the operation of the Company.
By: /s/ Roger Duffield Roger Duffield Chief Executive Officer and Chief Financial Officer (Principal Accounting, Executive and Financial Officer) February 21, 2012
|